1. Home
  2. NUCL vs CERS Comparison

NUCL vs CERS Comparison

Compare NUCL & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NUCL

Eagle Nuclear Energy Corp. Common stock

N/A

Current Price

$8.97

Market Cap

271.6M

ML Signal

N/A

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.01

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUCL
CERS
Founded
2023
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
EDP Services
Sector
Basic Materials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
271.6M
276.0M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
NUCL
CERS
Price
$8.97
$2.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
330.3K
1.4M
Earning Date
05-22-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.27
EPS
N/A
N/A
Revenue
N/A
$51,326,000.00
Revenue This Year
N/A
$19.95
Revenue Next Year
N/A
$8.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.68
52 Week Low
$4.63
$1.15
52 Week High
$9.00
$2.96

Technical Indicators

Market Signals
Indicator
NUCL
CERS
Relative Strength Index (RSI) 70.27 57.58
Support Level $6.86 $1.93
Resistance Level N/A $2.26
Average True Range (ATR) 0.81 0.09
MACD 0.21 0.04
Stochastic Oscillator 92.71 100.00

Price Performance

Historical Comparison
NUCL
CERS

About NUCL Eagle Nuclear Energy Corp. Common stock

Eagle Nuclear Energy Corp is a next-generation nuclear energy company that seeks to combine domestic uranium exploration and development with proprietary small modular reactor (SMR) technology. It holds the rights to the mineable, measured and indicated uranium deposit in the United States, referred to as the Aurora Uranium Project, located in southeastern Oregon. The Aurora Uranium Project includes the Aurora deposit, with an estimated 37.73 million pounds of near-surface uranium and the adjacent Cordex Zone Eagle's SMR technology. Eagle's mission is to supply uranium to the growing nuclear energy industry and play a role in the global transition to clean, reliable, and affordable energy.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: